No local recurrence of enchondroma after curettage and plaster filling.
BACKGROUND
The most common treatment of enchondromas is curettage (with or without adjuvant therapy) followed by cancellous bone grafting. To avoid donor-site morbidity of the iliac crest, we applied plaster of Paris as a bone defect filler after curettage of enchondromas.


METHODS
We treated 19 enchondromas of the hand and foot in 19 patients (mean age 40 years, range 21-79 years) with curettage and filling of the cavity with sterile plaster of Paris (calcium sulphate/phosphate) tablets.


RESULTS
The diagnosis was histologically confirmed in all cases. After a mean follow-up of 53 months (range 15-139 months), the mean functional Muskuloskeletal Tumor Society Score was 29.1 points (97%; range 28-30). There were no local recurrences although adjuvant therapy was not utilized.


CONCLUSIONS
Plaster of Paris appears safe and effective as a bone-filling substance after curettage of enchondroma.
Gaasbeek
R D A
RD
Department of Orthopaedic Surgery, Rijnstate Hospital, P.O. Box 9555, 6800 TA, Arnhem, The Netherlands. robert_gaasbeek@hetnet.nl
Rijnberg
W J
WJ
van Loon
C J M
CJ
Meyers
H
H
Feith
R
R
D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000601:surgery*; D018786:Bone Substitutes / Q000627:therapeutic use*; D002133:Calcium Sulfate / Q000627:therapeutic use*; D002812:Chondroma / Q000601:surgery*; D003475:Curettage; D005260:Female; D005500:Follow-Up Studies; D005528:Foot / Q000601:surgery; D006225:Hand / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets; D016896:Treatment Outcome
D018786:Bone Substitutes; D013607:Tablets; D002133:Calcium Sulfate